Single-Inhaler Triple vs Long-Acting Beta(2)-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical Practice. Suissa S, Dell'Aniello S, Ernst P. Chest 2025;167:712-723.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suissa S, Dell'Aniello S, Ernst P. Single-Inhaler Triple vs Long-Acting Beta(2)-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical Practice. Chest 2025;167:712-723.
PMID: 39461554